Rating Rationale
October 08, 2020 | Mumbai
Emerging Projects Private Limited
Rating migrated to 'CRISIL BB+/Stable'
 
Rating Action
Total Bank Loan Facilities Rated Rs.12 Crore
Long Term Rating CRISIL BB+/Stable (Migrated from 'CRISIL BB+/Stable  ISSUER NOT COOPERATING'*)
1 crore = 10 million
Refer to annexure for Details of Instruments & Bank Facilities
*Issuer did not cooperate; based on best-available information
Detailed Rationale

Due to inadequate information, CRISIL, in line with Securities and Exchange Board of India guidelines, had migrated the rating on the long-term bank facilities of Emerging Projects Private Limited (EPPL) to 'CRISIL BB+/Stable Issuer Not Cooperating'. However, the management has subsequently started sharing the requisite information for carrying out a comprehensive review of the rating.  Consequently, CRISIL is migrating the rating to 'CRISIL BB+/Stable'.
 
The rating continues to reflect the experience of the promoter in the healthcare industry and prudent working capital management. These strengths are partially offset by geographical concentration in revenue and exposure to intense competition. The ratings also factor in the limited impact of the nationwide lockdown imposed to contain the Covid-19 pandemic because of the essential nature of health services. Moreover, the increase in the number of beds by 30 to 150 in the current fiscal will aid revenue growth.

Analytical Approach

As on March 31, 2020, unsecured loans from the promoters reduced to Rs 0.52 crore from Rs 0.92 crore as on March 31, 2020. These loans have now been treated as debt as against 'neither debt nor equity' earlier because they are now not subordinated to bank debt and are being periodically repaid, as against CRISIL's earlier understanding.

Key Rating Drivers & Detailed Description
Strengths: 
* Extensive industry experience of the promoter: A presence of over two decades in the healthcare industry has enabled the promoter, Dr Anurag Kumar, to offer diverse medical services, resulting in healthy occupancy. The experience should help to maintain the market position over the medium term. However, the scale of operations remains low with revenue estimated at Rs 51 crore for fiscal 2020 (Rs 46 crore in fiscal 2019).
 
* Prudent working capital management: Gross current assets were low at 27 days as on March 31, 2020, driven by debtors of 11 days and inventory of 10 days. Despite the expected ramp-up in operations, working capital is likely to be managed efficiently over the medium term.
 
Weakness:
* Geographical concentration in revenue and exposure to intense competition: Operations are concentrated in the Moradabad region of Uttar Pradesh, unlike some large healthcare chains that have multiple hospitals in various locations resulting in a wider presence. The geographical concentration restricts the clientele and renders the company vulnerable to the dynamics of a single market and the entry of any big player in the region. Moreover, there is increased local competition from various hospitals, such as Kothiwal Dental College & Research Centre, Asian Vivekanand Super Specialty Hospital and Siddg Hospital. The image-sensitive nature of the healthcare industry further aggravates the risk of being in a single location. The company is likely to remain exposed to risks related to the modest scale of operations with geographical concentration, over the medium term.
Liquidity Stretched

Bank limit utilisation was high at around 97% during the 12 months through August 2020. Cash accrual is expected at Rs 3.5-4.0 crore, against term debt obligation of Rs 2.5-3.0 crore, per fiscal over the medium term. In addition, the emergency Covid-19 limit availed by the company aids liquidity. The current ratio was low at 0.31 time as on March 31, 2020. The promoter is likely to extend support in the form of equity and unsecured loans to meet working capital requirement and repayment obligation.

Outlook: Stable

CRISIL believes EPPL will continue to benefit from the extensive industry experience of the promoter.

Rating Sensitivity factors
Upward factor
* Sustained improvement in the operating margin to 15-18% and scale, leading to higher cash accrual
* Significant improvement in scale of operations
 
Downward factors
* A decline in net cash accrual to below Rs 2.75 crore on account of lower revenue or operating profit
* Large, debt-funded capital expenditure, weakening the capital structure
About the Company

Incorporated in 2008, EPPL runs a 120-bed multi-speciality, tertiary care Cosmos Hospital in Moradabad. The hospital, started in September 2011, provides medical care in 24 departments.

Key Financial Indicators
As on / for the period ended March 31   2020* 2019
Operating income Rs crore 51.02 45.64
Reported profit after tax (PAT) Rs crore 2.40 2.24
PAT margin % 4.70 4.91
Adjusted debt/adjusted networth Times 0.80 1.36
Interest coverage Times 5.26 5.27
*Provisional

Status of non cooperation with previous CRA:
EPPL has not cooperated with Brickwork Ratings India Private Limited which has classified it as non-cooperative vide release dated June 29, 2020. The reason provided by Brickwork Ratings India Private Limited is non-furnishing of information for monitoring of ratings.

Any other information: Not applicable

Note on complexity levels of the rated instrument:
CRISIL complexity levels are assigned to various types of financial instruments and are included (where applicable) in the Annexure -- Details of Instrument in this Rating Rationale. For more details on the CRISIL complexity levels, please visit www.crisil.com/complexity-levels.
Annexure - Details of Instrument(s)
ISIN Name of Instrument Date of Allotment Coupon
Rate (%)
Maturity Date Issue Size
(Rs. Cr)
Complexity Level Rating Assigned  with Outlook
NA Overdraft NA NA NA 4.50 NA CRISIL BB+/Stable
NA Term Loan NA NA Mar-2022 7.50 NA CRISIL BB+/Stable
Annexure - Rating History for last 3 Years
  Current 2020 (History) 2019  2018  2017  Start of 2017
Instrument Type Outstanding Amount Rating Date Rating Date Rating Date Rating Date Rating Rating
Fund-based Bank Facilities  LT/ST  12.00  CRISIL BB+/Stable  27-05-20  CRISIL BB+/Stable (Issuer Not Cooperating)*  21-02-19  CRISIL BB+/Stable      27-12-17  CRISIL BB+/Stable  CRISIL BB/Stable 
                    05-09-17  CRISIL BB/Stable (Issuer Not Cooperating)*   
All amounts are in Rs.Cr.
*Issuer did not cooperate; based on best-available information
Annexure - Details of various bank facilities
Current facilities Previous facilities
Facility Amount (Rs.Crore) Rating Facility Amount (Rs.Crore) Rating
Overdraft 4.5 CRISIL BB+/Stable Overdraft 3.5 CRISIL BB+/Stable/Issuer Not Cooperating 
Term Loan 7.5 CRISIL BB+/Stable Term Loan 8.5 CRISIL BB+/Stable/Issuer Not Cooperating 
Total 12 -- Total 12 --
Links to related criteria
Assessing Information Adequacy Risk
CRISILs Approach to Financial Ratios
CRISILs Bank Loan Ratings - process, scale and default recognition
Rating criteria for manufaturing and service sector companies

For further information contact:
Media Relations
Analytical Contacts
Customer Service Helpdesk
Saman Khan
Media Relations
CRISIL Limited
D: +91 22 3342 3895
B: +91 22 3342 3000
saman.khan@crisil.com

Naireen Ahmed
Media Relations
CRISIL Limited
D: +91 22 3342 1818
B: +91 22 3342 3000
naireen.ahmed@crisil.com

Nitin Kansal
Director - CRISIL Ratings
CRISIL Limited
D:+91 124 672 2154
nitin.kansal@crisil.com


Himank Sharma
Associate Director - CRISIL Ratings
CRISIL Limited
D:+91 124 672 2152
Himank.Sharma@crisil.com


Devansh Jain
Rating Analyst - CRISIL Ratings
CRISIL Limited
B:+91 124 672 2000
Devansh.Jain@crisil.com
Timings: 10.00 am to 7.00 pm
Toll free Number:1800 267 1301

For a copy of Rationales / Rating Reports:
CRISILratingdesk@crisil.com
 
For Analytical queries:
ratingsinvestordesk@crisil.com


 

Note for Media:
This rating rationale is transmitted to you for the sole purpose of dissemination through your newspaper / magazine / agency. The rating rationale may be used by you in full or in part without changing the meaning or context thereof but with due credit to CRISIL. However, CRISIL alone has the sole right of distribution (whether directly or indirectly) of its rationales for consideration or otherwise through any media including websites, portals etc.


About CRISIL Limited

CRISIL is a leading agile and innovative, global analytics company driven by its mission of making markets function better. We are India’s foremost provider of ratings, data, research, analytics and solutions. A strong track record of growth, culture of innovation and global footprint sets us apart. We have delivered independent opinions, actionable insights, and efficient solutions to over 1,00,000 customers.
 
We are majority owned by S&P Global Inc., a leading provider of transparent and independent ratings, benchmarks, analytics and data to the capital and commodity markets worldwide.
 
For more information, visit www.crisil.com 


Connect with us: TWITTER | LINKEDIN | YOUTUBE | FACEBOOK

About CRISIL Ratings
CRISIL Ratings is part of CRISIL Limited (“CRISIL”). We pioneered the concept of credit rating in India in 1987. CRISIL is registered in India as a credit rating agency with the Securities and Exchange Board of India (“SEBI”). With a tradition of independence, analytical rigour and innovation, CRISIL sets the standards in the credit rating business. We rate the entire range of debt instruments, such as, bank loans, certificates of deposit, commercial paper, non-convertible / convertible / partially convertible bonds and debentures, perpetual bonds, bank hybrid capital instruments, asset-backed and mortgage-backed securities, partial guarantees and other structured debt instruments. We have rated over 24,500 large and mid-scale corporates and financial institutions. CRISIL has also instituted several innovations in India in the rating business, including rating municipal bonds, partially guaranteed instruments and microfinance institutions. We also pioneered a globally unique rating service for Micro, Small and Medium Enterprises (MSMEs) and significantly extended the accessibility to rating services to a wider market. Over 1,10,000 MSMEs have been rated by us.


CRISIL PRIVACY
 
CRISIL respects your privacy. We may use your contact information, such as your name, address, and email id to fulfil your request and service your account and to provide you with additional information from CRISIL.For further information on CRISIL’s privacy policy please visit www.crisil.com.


DISCLAIMER

This disclaimer forms part of and applies to each credit rating report and/or credit rating rationale that we provide (each a “Report”). For the avoidance of doubt, the term “Report” includes the information, ratings and other content forming part of the Report. The Report is intended for the jurisdiction of India only. This Report does not constitute an offer of services. Without limiting the generality of the foregoing, nothing in the Report is to be construed as CRISIL providing or intending to provide any services in jurisdictions where CRISIL does not have the necessary licenses and/or registration to carry out its business activities referred to above. Access or use of this Report does not create a client relationship between CRISIL and the user.

We are not aware that any user intends to rely on the Report or of the manner in which a user intends to use the Report. In preparing our Report we have not taken into consideration the objectives or particular needs of any particular user. It is made abundantly clear that the Report is not intended to and does not constitute an investment advice. The Report is not an offer to sell or an offer to purchase or subscribe for any investment in any securities, instruments, facilities or solicitation of any kind or otherwise enter into any deal or transaction with the entity to which the Report pertains. The Report should not be the sole or primary basis for any investment decision within the meaning of any law or regulation (including the laws and regulations applicable in the US).

Ratings from CRISIL Rating are statements of opinion as of the date they are expressed and not statements of fact or recommendations to purchase, hold, or sell any securities / instruments or to make any investment decisions. Any opinions expressed here are in good faith, are subject to change without notice, and are only current as of the stated date of their issue. CRISIL assumes no obligation to update its opinions following publication in any form or format although CRISIL may disseminate its opinions and analysis. CRISIL rating contained in the Report is not a substitute for the skill, judgment and experience of the user, its management, employees, advisors and/or clients when making investment or other business decisions. The recipients of the Report should rely on their own judgment and take their own professional advice before acting on the Report in any way.CRISIL or its associates may have other commercial transactions with the company/entity.

Neither CRISIL nor its affiliates, third party providers, as well as their directors, officers, shareholders, employees or agents (collectively, “CRISIL Parties”) guarantee the accuracy, completeness or adequacy of the Report, and no CRISIL Party shall have any liability for any errors, omissions, or interruptions therein, regardless of the cause, or for the results obtained from the use of any part of the Report. EACH CRISIL PARTY DISCLAIMS ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, ANY WARRANTIES OF MERCHANTABILITY, SUITABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE. In no event shall any CRISIL Party be liable to any party for any direct, indirect, incidental, exemplary, compensatory, punitive, special or consequential damages, costs, expenses, legal fees, or losses (including, without limitation, lost income or lost profits and opportunity costs) in connection with any use of any part of the Report even if advised of the possibility of such damages.

CRISIL Ratings may receive compensation for its ratings and certain credit-related analyses, normally from issuers or underwriters of the instruments, facilities, securities or from obligors. CRISIL’s public ratings and analysis as are required to be disclosed under the regulations of the Securities and Exchange Board of India (and other applicable regulations, if any) are made available on its web sites, www.crisil.com (free of charge). Reports with more detail and additional information may be available for subscription at a fee – more details about CRISIL ratings are available here: www.crisilratings.com.

CRISIL and its affiliates do not act as a fiduciary. While CRISIL has obtained information from sources it believes to be reliable, CRISIL does not perform an audit and undertakes no duty of due diligence or independent verification of any information it receives and / or relies in its Reports. CRISIL keeps certain activities of its business units separate from each other in order to preserve the independence and objectivity of the respective activity. As a result, certain business units of CRISIL may have information that is not available to other CRISIL business units. CRISIL has established policies and procedures to maintain the confidentiality of certain non-public information received in connection with each analytical process. CRISIL has in place a ratings code of conduct and policies for analytical firewalls and for managing conflict of interest. For details please refer to: https://www.crisil.com/en/home/our-businesses/ratings/regulatory-disclosures/highlighted-policies.html

CRISIL’s rating criteria are generally available without charge to the public on the CRISIL public web site, www.crisil.com. For latest rating information on any instrument of any company rated by CRISIL you may contact CRISIL RATING DESK at CRISILratingdesk@crisil.com, or at (0091) 1800 267 1301.

This Report should not be reproduced or redistributed to any other person or in any form without a prior written consent of CRISIL.

All rights reserved @ CRISIL